Literature DB >> 14692890

Rapidly reversible dementia in cerebral amyloid inflammatory vasculopathy.

K A C Harkness1, A Coles, U Pohl, J H Xuereb, J C Baron, G G Lennox.   

Abstract

This report discusses a biopsy proven case of cerebral amyloid angiopathy, with additional prominent vascular inflammatory features, characterized by a rapidly progressive dementia and leukoencephalopathy, where the clinical and radiological abnormalities resolved rapidly with minimal therapeutic intervention. We propose the term cerebral amyloid inflammatory vasculopathy (CAIV) to describe this condition.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14692890     DOI： 10.1046/j.1351-5101.2003.00707.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN： 1351-5101            Impact factor:   6.089


  14 in total

1.  Cerebral amyloid angiopathy related vasculitis: successful treatment with azathioprine.

Authors:  Sebastian Luppe; Samar Betmouni; Neil Scolding; Alastair Wilkins
Journal:  J Neurol       Date:  2010-07-15       Impact factor: 4.849

2.  Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein.

Authors:  Jianting Miao; Feng Xu; Judianne Davis; Irene Otte-Höller; Marcel M Verbeek; William E Van Nostrand
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

3.  Reducing cerebral microvascular amyloid-beta protein deposition diminishes regional neuroinflammation in vasculotropic mutant amyloid precursor protein transgenic mice.

Authors:  Jianting Miao; Michael P Vitek; Feng Xu; Mary Lou Previti; Judianne Davis; William E Van Nostrand
Journal:  J Neurosci       Date:  2005-07-06       Impact factor: 6.167

4.  Corticosteroids, but not NSAIDs, are associated with less Alzheimer neuropathology.

Authors:  Michal Schnaider Beeri; James Schmeidler; Gerson T Lesser; Maria Maroukian; Rebecca West; Stephanie Leung; Michael Wysocki; Daniel P Perl; Dushyant P Purohit; Vahram Haroutunian
Journal:  Neurobiol Aging       Date:  2011-04-01       Impact factor: 4.673

5.  Early-onset subicular microvascular amyloid and neuroinflammation correlate with behavioral deficits in vasculotropic mutant amyloid beta-protein precursor transgenic mice.

Authors:  F Xu; A M Grande; J K Robinson; M L Previti; M Vasek; J Davis; W E Van Nostrand
Journal:  Neuroscience       Date:  2007-02-28       Impact factor: 3.590

Review 6.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Aissa Haman; Bruce L Miller
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

7.  Early-onset formation of parenchymal plaque amyloid abrogates cerebral microvascular amyloid accumulation in transgenic mice.

Authors:  Feng Xu; AnnMarie E Kotarba; Ming-Hsuan Ou-Yang; Ziao Fu; Judianne Davis; Steven O Smith; William E Van Nostrand
Journal:  J Biol Chem       Date:  2014-05-14       Impact factor: 5.157

Review 8.  Rapidly Progressive Dementia.

Authors:  Michael D Geschwind
Journal:  Continuum (Minneap Minn)       Date:  2016-04

9.  Cerebral amyloid angiopathy-related inflammation presenting with steroid-responsive higher brain dysfunction: case report and review of the literature.

Authors:  Hideya Sakaguchi; Akihiko Ueda; Takayuki Kosaka; Satoshi Yamashita; En Kimura; Taro Yamashita; Yasushi Maeda; Teruyuki Hirano; Makoto Uchino
Journal:  J Neuroinflammation       Date:  2011-09-14       Impact factor: 8.322

10.  Intrathecal corticosteroids might slow Alzheimer's disease progression.

Authors:  Joseph Martin Alisky
Journal:  Neuropsychiatr Dis Treat       Date:  2008-10       Impact factor: 2.570
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.